ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

OTLK Outlook Therapeutics Inc

7.31
-0.25 (-3.31%)
18 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Outlook Therapeutics Inc OTLK NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.25 -3.31% 7.31 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
7.58 7.054 7.84 7.07 7.56
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/6/202415:10EDGAR2Form PRE 14A - Other preliminary proxy statements
11/6/202408:05GLOBEOutlook Therapeutics® to Present at the Virtual Investor..
28/5/202407:05GLOBEOutlook Therapeutics® Receives European Commission Marketing..
15/5/202416:19EDGAR2Form 8-K - Current report
15/5/202416:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202416:00GLOBEOutlook Therapeutics® Reports Financial Results for Second..
13/5/202415:05EDGAR2Form 8-K - Current report
13/5/202407:50GLOBEOutlook Therapeutics® Announces UK Submission of Marketing..
09/5/202407:45GLOBEOutlook Therapeutics® to Report Financial Results for Second..
06/5/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
06/5/202415:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/5/202408:05GLOBEOutlook Therapeutics® to Present at the Retina World..
29/4/202408:00GLOBEOutlook Therapeutics® to Present at the Ophthalmology..
15/4/202415:15GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
22/3/202406:35GLOBEOutlook Therapeutics® Receives European Union Positive CHMP..
18/3/202416:10GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
12/3/202407:05GLOBEOutlook Therapeutics® Announces Effective Date for 1-for-20..
11/3/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:16EDGAR2Form 8-K - Current report
14/2/202416:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202415:40EDGAR2Form 8-K - Current report
14/2/202407:05GLOBEOutlook Therapeutics® Reports Financial Results for First..
08/2/202405:59EDGAR2Form DEF 14A - Other definitive proxy statements
31/1/202415:01EDGAR2Form SC 13D/A - General statement of acquisition of..
31/1/202407:05GLOBEOutlook Therapeutics® Doses First Subject in NORSE EIGHT
29/1/202416:00EDGAR2Form PRE 14A - Other preliminary proxy statements
24/1/202416:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24/1/202405:02EDGAR2Form 8-K - Current report
23/1/202407:00GLOBEOutlook Therapeutics® Receives FDA Agreement Under Special..
22/12/202316:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/12/202315:15EDGAR2Form 8-K - Current report
22/12/202307:05GLOBEOutlook Therapeutics® Reports Financial Results for Fiscal..
19/12/202307:05GLOBEOutlook Therapeutics® Submits Special Protocol Assessment..
18/12/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
06/12/202316:00EDGAR2Form 8-K - Current report
06/12/202307:05GLOBEOutlook Therapeutics® Announces Strategic Organizational..
04/12/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
29/11/202315:01EDGAR2Form SC 13D/A - General statement of acquisition of..
28/11/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
27/11/202307:05GLOBEOutlook Therapeutics® Announces Receipt of Type A Meeting..
21/11/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
14/11/202307:05GLOBEOutlook Therapeutics® Adds Global Commercial Expertise with..
14/11/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
02/11/202307:12EDGAR2Form 8-K - Current report
02/11/202307:05GLOBEOutlook Therapeutics® Provides Update on Type A Meetings..
01/11/202307:05GLOBEOutlook Therapeutics® to Present at Guggenheim’s 5th Annual..

Su Consulta Reciente

Delayed Upgrade Clock